Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML-Reference-Cited by-同舟云学术

Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML

Published:2012-09-30 Issue:11 Volume:8 Page:905-912
ISSN:1552-4450
Container-title:Nature Chemical Biology
language:en
Short-container-title:Nat Chem Biol

Author:

Winter Georg E,Rix Uwe,Carlson Scott M,Gleixner Karoline V,Grebien Florian,Gridling Manuela,Müller André C,Breitwieser Florian P,Bilban Martin,Colinge Jacques,Valent Peter,Bennett Keiryn L,White Forest M,Superti-Furga Giulio

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/nchembio.1085.pdf

Reference45 articles.

1. Kitano, H. Cancer as a robust system: implications for anticancer therapy. Nat. Rev. Cancer 4, 227–235 (2004).

2. Lehár, J. et al. Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat. Biotechnol. 27, 659–666 (2009).

3. Lamb, J. et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929–1935 (2006).

4. Rix, U. & Superti-Furga, G. Target profiling of small molecules by chemical proteomics. Nat. Chem. Biol. 5, 616–624 (2009).

5. Pan, C., Olsen, J.V., Daub, H. & Mann, M. Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics. Mol. Cell. Proteomics 8, 2796–2808 (2009).

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring affinity chromatography in proteomics: A comprehensive review;Analytica Chimica Acta;2024-06

2. Analytical Methods in Pharmacoproteomics: A Systematic Review;Pharmacoproteomics;2024

3. Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic ductal adenocarcinoma;Cancer Letters;2022-12

4. DeepIDC: A Prediction Framework of Injectable Drug Combination Based on Heterogeneous Information and Deep Learning;Clinical Pharmacokinetics;2022-11-11

5. Kinase-targeting small-molecule inhibitors and emerging bifunctional molecules;Trends in Pharmacological Sciences;2022-10